Alpha Tau Medical Ltd.

2.48
-0.10 (-3.88%)
At close: Apr 03, 2025, 3:59 PM
2.48
0.33%
Pre-market: Apr 04, 2025, 04:06 AM EDT
-3.88%
Bid 2.45
Market Cap 174.19M
Revenue (ttm) n/a
Net Income (ttm) n/a
EPS (ttm) -0.45
PE Ratio (ttm) -5.5
Forward PE -8.27
Analyst Buy
Ask 2.85
Volume 21,140
Avg. Volume (20D) 92,665
Open 2.46
Previous Close 2.58
Day's Range 2.45 - 2.50
52-Week Range 1.75 - 4.39
Beta 0.87

About DRTS

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and othe...

Industry Biotechnology
Sector Healthcare
IPO Date Mar 8, 2021
Employees 125
Stock Exchange NASDAQ
Ticker Symbol DRTS
Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for DRTS stock is "Buy." The 12-month stock price forecast is $8, which is an increase of 223.23% from the latest price.

Stock Forecasts